PHARMACOLOGICAL ASPECTS OF THE DEVELOPMENT OF SELECTIVE SYNTHETIC THROMBIN INHIBITORS AS ANTICOAGULANTS

被引：47
作者：
HAUPTMANN, J
MARKWARDT, F
机构：
[1] Institute Pharmacology/Toxicology, Medical Academy Erfurt, D-O-5010 Erfurt
来源：
SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1992年 / 18卷 / 02期
关键词：
D O I：
10.1055/s-2007-1002426
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：200 / 217
页数：18
相关论文
共 155 条
[21]  
GLUSA E, 1982, Folia Haematologica (Leipzig), V109, P98
[22]  
GOLD HK, 1990, FIBRINOLYSIS S, V3, P15
[23]  
GRECO NJ, 1990, BLOOD, V75, P1983
[24]   INVITRO STUDIES OF A NEW SYNTHETIC THROMBIN INHIBITOR [J].
GREEN, D ;
TSAO, CH ;
REYNOLDS, N ;
KAHN, D ;
KOHL, H ;
COHEN, I .
THROMBOSIS RESEARCH, 1985, 37 (01) :145-153
[25]   INTERRUPTION OF ACUTE PLATELET-DEPENDENT THROMBOSIS BY THE SYNTHETIC ANTITHROMBIN D-PHENYLALANYL-L-PROLYL-L-ARGINYL CHLOROMETHYL KETONE [J].
HANSON, SR ;
HARKER, LA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (09) :3184-3188
[26]  
HARA H, 1980, Kobe Journal of Medical Sciences, V26, P47
[27]  
HARA H, 1987, THROMB HAEMOSTASIS, V57, P165
[28]   COMPARATIVE BEHAVIOR OF THROMBIN AND AN INACTIVE DERIVATIVE, FPR-THROMBIN, TOWARD THE RABBIT VASCULAR ENDOTHELIUM - HEPARIN LIBERATES FPR-THROMBIN FROM THE ENDOTHELIUM INVIVO [J].
HATTON, MWC ;
MOAR, SL .
CIRCULATION RESEARCH, 1990, 67 (01) :221-229
[29]  
HAUPTMANN J, 1985, THROMB RES, V39, P771, DOI 10.1016/0049-3848(85)90262-2
[30]  
HAUPTMANN J, 1982, Folia Haematologica (Leipzig), V109, P89
12345678910